| |
STARPHARMA HOLDINGS LIMITED Company Summary |
|
 Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc in Michigan, USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents.
The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes. |
|
|
|
 Jackie Fairley BSc, BVSc (Hons), MBA
Chief Executive Officer
Dr Fairley has over 15 years' experience in the pharmaceutical and biotechnology industries working in business development and senior management roles with companies including CSL and Faulding (now Mayne Pharma). Prior to joining Starpharma as COO in 2005, she was CEO of Cerylid Biosciences Limited. During her time as CEO of Cerylid, the company generated revenues of over $20 million, raised more than $10 million private equity funding and completed the acquisition and integration of a private kinase company. Prior to joining the biotechnology sector, Dr Fairley spent 5 years as a Vice President for Faulding's injectable division where she was responsible for the group's global business development activities and injectable development program supporting product sales of > $200 million into 70 countries. She is a member of the Federal Government's Pharmaceutical Industry Working Group, and the Victorian Innovation Economy Advisory Board.
|
|
|
|
|
 |
Headquarters |
Baker Building |
 |
| |
|
75 Commercial Road |
|
| |
|
Melbourne VIC 3004 |
|
| |
|
AUSTRALIA |
|
|
Telephone |
+61 3 8532 2700 |
|
|
Fax |
+61 3 9510 5955 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
2000/09/28 |
|
|
Homepage |
www.starpharma.com |
|
| |
|
|
|
|
| |
NEWS |
 |
|
|  Starpharma Holdings Limited (ASX:SPL) Announce Final Report and Annual Results (AUG 27, 2008) | | Starpharma Holdings Limited (ASX:SPL) Announce New VivaGel(R) Clinical Trial Commences (AUG 13, 2008) | | Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) Announce New Indication for VivaGel(R): Bacterial Vaginosis (JULY 9, 2008) | | Starpharma Holdings Limited (ASX:SPL) Reports Positive VivaGel(R) Clinical Study Results (MAY 12, 2008) | | Starpharma Holdings (ASX:SPL) Advise Opes Prime Overhang Cleared (APR 24, 2008) | | Starpharma Holdings (ASX:SPL) Announce Commercial Product Launch Of Priostar(R) Dendrimer Technology As NanoJuiceTM (APR 22, 2008) | | Starpharma Holdings (ASX:SPL) Excellence In Biotechnology Investment 2008 Conference - CEO Investor Presentation (APR 21, 2008) | | Starpharma Holdings (ASX:SPL) Studies Show That VivaGel Inhibits Clinically Relevant Strains Of Human Papillomavirus (HPV) In Laboratory Tests (APR 21, 2008) | | Starpharma Limited (ASX:SPL) Files Patent For Dendrimer Potential in Arthritic Applications (APR 14, 2008) | | Starpharma Holdings (ASX:SPL) Signs Research Agreement With Unilever For Dendrimer Technology (APR 7, 2008) | | Aust Market Wrap, (ASX: STO), (ASX: GWR), (ASX: SEV), (ASX: OST), (ASX: WES), (ASX: SPL), (ASX: FAS) (OCT 16, 2007) |
|
|
|
|
|  Starpharma Holdings Limited ASX: SPL - 2007 AGM CEO's Address - Dr Jackie Fairley, CEO (NOV 15, 2007) | | Starpharma Holdings Limited ASX: SPL - Co-development Agreement With Durex For Condoms With VivaGel - Dr Jackie Fairley, CEO (OCT 16, 2007) | | Starpharma Holdings Limited ASX: SPL - US NIH Funded Trial Of VivaGel Commences - Dr Jackie Fairley, CEO (JULY 11, 2007) | | Starpharma Holdings Limited ASX: SPL - Starpharma Joins Premier US OTC Index - Dr Jackie Fairley, CEO (APR 3, 2007) | | Starpharma Holdings Limited ASX: SPL - 2006 AGM Chairman's Address - Mr Peter Bartels, Chairman (NOV 15, 2006) | | Starpharma Holdings Limited ASX: SPL - 2006 AGM CEO's Address - Dr Jackie Fairley, CEO (NOV 15, 2006) | | Starpharma Holdings Limited ASX: SPL - To Acquire Dendritic Nanotechnologies Inc - Dr Jackie Fairley, CEO (OCT 11, 2006) | | STARPHARMA HOLDINGS LIMITED ASX: SPL - VivaGel IND for Genital Herpes Trial clears US FDA - Dr Jackie Fairley, CEO (JULY 21, 2006) | | STARPHARMA HOLDINGS LIMITED ASX: SPL - Update on lead product VivaGel - Ms Jackie Fairley, Chief Operating Officer (JUNE 16, 2006) |
|
|
|
|
